Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-12-05 Purchase | 2025-12-08 9:45 pm | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR | 128,699 | $4.304 | $553,917 | 201,513 (Direct) | View |
| 2025-12-05 Purchase | 2025-12-08 9:45 pm | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER | 50,000 | $4.22 | $211,000 | 80,189 (Direct) | View |
| 2025-12-04 Sale | 2025-12-05 6:20 pm | Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner | 524,560 | $4.1947 | $2,200,372 | 2,149,880 (Indirect Direct) | View |
| 2025-12-01 Sale | 2025-12-03 9:39 pm | Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner | 574,886 | $4.1884 | $2,407,833 | 2,620,440 (Indirect Direct) | View |
| 2025-05-15 Sale | 2025-05-16 4:46 pm | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER | 2,960 | $2 | $5,920 | 39,154 (Direct) | View |
| 2025-05-15 Sale | 2025-05-16 4:45 pm | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER | 924 | $2 | $1,848 | 13,768 (Direct) | View |
| 2025-05-15 Sale | 2025-05-16 4:44 pm | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR | 9,126 | $2 | $18,252 | 87,488 (Direct) | View |
| 2025-03-26 Purchase(A) | 2025-04-28 3:31 pm | Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner | 37,000 | $5.1062 | $188,931 | 2,864,561 (Indirect Direct) | View |
| 2025-03-26 Purchase | 2025-04-28 3:24 pm | Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner | 37,000 | $5.1062 | $188,931 | 2,864,561 (Indirect Direct) | View |
| 2025-04-22 Purchase | 2025-04-24 09:35 am | Adverum Biotechnologies Inc. | ADVM | Leonard Braden Michael 10% Owner | 350,000 | $2.997 | $1,048,950 | 3,249,326 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-09 Exercise | 2025-12-10 1:52 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR | 150,000 | $4.2 | 0 (Direct) | View |
| 2025-12-09 Equity Swap | 2025-12-10 1:52 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR | 899,179 | $0 | 0 (Direct) | View |
| 2025-12-09 Option Award | 2025-12-10 1:52 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR | 500,000 | $0 | 0 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-10 1:52 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR | 150,000 | $0 | 0 (Direct) | View |
| 2025-12-09 Equity Swap | 2025-12-10 1:49 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER | 250,647 | $0 | 0 (Direct) | View |
| 2025-12-09 Option Award | 2025-12-10 1:49 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER | 150,000 | $0 | 0 (Direct) | View |
| 2025-12-09 Equity Swap | 2025-12-10 1:46 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer | 93,125 | $0 | 0 (Direct) | View |
| 2025-12-09 Option Award | 2025-12-10 1:46 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer | 85,000 | $0 | 0 (Direct) | View |
| 2025-12-09 Equity Swap | 2025-12-10 1:44 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER | 151,331 | $0 | 0 (Direct) | View |
| 2025-12-09 Option Award | 2025-12-10 1:44 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER | 85,000 | $0 | 0 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-10 1:41 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M CHIEF FINANCIAL OFFICER | 48,750 | $4.2 | 0 (Direct) | View |
| 2025-12-09 Equity Swap | 2025-12-10 1:41 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M CHIEF FINANCIAL OFFICER | 111,275 | $0 | 0 (Direct) | View |
| 2025-12-09 Option Award | 2025-12-10 1:41 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M CHIEF FINANCIAL OFFICER | 42,000 | $0 | 0 (Direct) | View |
| 2025-12-09 Exercise | 2025-12-10 1:41 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M CHIEF FINANCIAL OFFICER | 48,750 | $0 | 0 (Direct) | View |
| 2025-12-09 Equity Swap | 2025-12-10 1:31 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 5,000 | $0 | 0 (Direct) | View |
| 2025-12-09 Equity Swap | 2025-12-10 1:29 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director | 10,333 | $0 | 0 (Direct) | View |
| 2025-12-09 Equity Swap | 2025-12-10 1:25 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director | 13,000 | $0 | 0 (Direct) | View |
| 2025-12-09 Equity Swap | 2025-12-10 1:22 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director | 8,818 | $0 | 0 (Direct) | View |
| 2025-12-09 Equity Swap | 2025-12-09 5:29 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Frazier Life Sciences Public Fund L.P. FHMLSP L.P. FHMLSP L.L.C. 10% Owner | 4,288,949 | $3.56 | 0 (Direct) | View |
Ownership | 2025-12-05 4:41 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Frazier Life Sciences Public Fund L.P. FHMLSP L.P. FHMLSP L.L.C. 10% Owner | 0 | $0 | 4,288,949 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:29 pm | N/A 2029-10-29 | Adverum Biotechnologies Inc. | ADVM | Soparkar Peter CHIEF OPERATING OFFICER | 197,048 | $0 | 197,048 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:29 pm | N/A 2032-01-05 | Adverum Biotechnologies Inc. | ADVM | Seyedkazemi Setareh CHIEF DEVELOPMENT OFFICER | 91,000 | $0 | 91,000 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:28 pm | N/A 2033-08-02 | Adverum Biotechnologies Inc. | ADVM | Rubinstein Linda M CHIEF FINANCIAL OFFICER | 120,000 | $0 | 120,000 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:28 pm | N/A 2032-03-16 | Adverum Biotechnologies Inc. | ADVM | Ozden Rabia Gurses Chief Medical Officer | 12,000 | $0 | 12,000 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:27 pm | N/A 2030-06-14 | Adverum Biotechnologies Inc. | ADVM | Fischer Laurent CEO, PRESIDENT AND DIRECTOR | 564,418 | $0 | 564,418 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:26 pm | N/A 2035-06-16 | Adverum Biotechnologies Inc. | ADVM | Kiss Szilard Director | 10,450 | $0 | 10,450 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:26 pm | N/A 2035-06-16 | Adverum Biotechnologies Inc. | ADVM | Scopa James Paul Director | 10,450 | $0 | 10,450 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:25 pm | N/A 2035-06-16 | Adverum Biotechnologies Inc. | ADVM | Whitcup Scott M Director | 10,450 | $0 | 10,450 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:24 pm | N/A 2035-06-16 | Adverum Biotechnologies Inc. | ADVM | Tuckson Reed Vaughn Director | 10,450 | $0 | 10,450 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:24 pm | N/A 2035-06-16 | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 10,450 | $0 | 10,450 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:23 pm | N/A 2035-06-16 | Adverum Biotechnologies Inc. | ADVM | Lupher Jr. Mark L. Director | 10,450 | $0 | 10,450 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:23 pm | N/A 2035-06-16 | Adverum Biotechnologies Inc. | ADVM | Hong Soo Director | 10,450 | $0 | 10,450 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:22 pm | N/A 2035-06-16 | Adverum Biotechnologies Inc. | ADVM | Nicholson C. David Director | 10,450 | $0 | 10,450 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:21 pm | N/A 2035-06-16 | Adverum Biotechnologies Inc. | ADVM | Machado Patrick Director | 13,590 | $0 | 13,590 (Direct) | View |